AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,648,000 | +114.4% | 307,232 | +6.3% | 1.25% | +111.5% |
| Q2 2022 | $2,168,000 | -17.6% | 289,040 | 0.0% | 0.59% | -13.7% |
| Q1 2022 | $2,630,000 | +29.6% | 289,040 | 0.0% | 0.68% | +34.3% |
| Q4 2021 | $2,029,000 | -38.4% | 289,040 | 0.0% | 0.51% | -41.6% |
| Q3 2021 | $3,295,000 | -28.8% | 289,040 | 0.0% | 0.87% | -9.7% |
| Q2 2021 | $4,628,000 | -6.1% | 289,040 | +4.8% | 0.97% | -17.2% |
| Q1 2021 | $4,929,000 | +26.5% | 275,840 | -4.4% | 1.17% | +0.8% |
| Q4 2020 | $3,897,000 | +16.4% | 288,440 | +1.4% | 1.16% | +6.6% |
| Q3 2020 | $3,348,000 | -18.8% | 284,440 | +1.8% | 1.09% | -8.6% |
| Q2 2020 | $4,125,000 | +4.1% | 279,440 | -4.8% | 1.19% | -28.0% |
| Q1 2020 | $3,961,000 | -38.8% | 293,440 | +9.6% | 1.65% | -25.6% |
| Q4 2019 | $6,474,000 | +17.0% | 267,839 | -6.9% | 2.22% | +6.8% |
| Q3 2019 | $5,531,000 | -8.9% | 287,748 | +40.1% | 2.08% | -8.9% |
| Q2 2019 | $6,071,000 | -15.8% | 205,440 | +35.4% | 2.28% | -26.6% |
| Q1 2019 | $7,209,000 | +40.9% | 151,770 | +7.1% | 3.11% | +22.2% |
| Q4 2018 | $5,118,000 | -37.4% | 141,770 | +6.8% | 2.54% | -24.2% |
| Q3 2018 | $8,172,000 | -8.2% | 132,770 | +0.8% | 3.36% | -19.5% |
| Q2 2018 | $8,901,000 | +23.6% | 131,770 | -0.8% | 4.17% | +18.9% |
| Q1 2018 | $7,203,000 | +3.2% | 132,770 | +13.7% | 3.50% | -6.7% |
| Q4 2017 | $6,977,000 | +22.9% | 116,770 | 0.0% | 3.76% | +6.6% |
| Q3 2017 | $5,675,000 | +1.1% | 116,770 | +9.4% | 3.52% | -12.0% |
| Q2 2017 | $5,611,000 | +164.5% | 106,770 | +128.3% | 4.00% | +123.2% |
| Q1 2017 | $2,121,000 | -43.0% | 46,770 | -52.5% | 1.79% | -45.2% |
| Q4 2016 | $3,723,000 | +7.4% | 98,370 | +7.1% | 3.27% | +35.4% |
| Q3 2016 | $3,467,000 | +22.5% | 91,869 | -42.9% | 2.42% | +7.6% |
| Q2 2016 | $2,831,000 | +29.5% | 160,869 | -10.5% | 2.24% | +19.0% |
| Q1 2016 | $2,186,000 | -39.5% | 179,769 | +21.2% | 1.89% | -41.4% |
| Q4 2015 | $3,613,000 | +22.9% | 148,369 | -10.4% | 3.22% | +10.5% |
| Q3 2015 | $2,939,000 | +6.2% | 165,669 | +5.6% | 2.92% | +24.6% |
| Q2 2015 | $2,768,000 | -44.9% | 156,842 | -2.1% | 2.34% | -39.3% |
| Q1 2015 | $5,022,000 | +29.9% | 160,242 | +21.0% | 3.86% | +26.1% |
| Q4 2014 | $3,866,000 | +28.6% | 132,442 | -8.9% | 3.06% | +0.8% |
| Q3 2014 | $3,007,000 | – | 145,342 | – | 3.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|